L-Arginine causes whereas L-argininosuccinic acid inhibits endothelium-dependent vascular smooth muscle relaxation
- 31 May 1989
- journal article
- research article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 161 (2), 536-543
- https://doi.org/10.1016/0006-291x(89)92632-6
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxationBiochemical and Biophysical Research Communications, 1988
- Vascular endothelial cells synthesize nitric oxide from L-arginineNature, 1988
- Is arginine a physiological precursor of endothelium-derived nitric oxide?European Journal of Pharmacology, 1988
- Endothelium-derived relaxing factor from pulmonary artery and vein possesses pharmacologic and chemical properties identical to those of nitric oxide radical.Circulation Research, 1987
- Comparative pharmacology of endothelium‐derived relaxing factor, nitric oxide and prostacyclin in plateletsBritish Journal of Pharmacology, 1987
- Comparative pharmacology of EDRF and nitric oxide on vascular stripsEuropean Journal of Pharmacology, 1987
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Endothelium‐dependent inhibition of platelet aggregationBritish Journal of Pharmacology, 1986
- Evidence for the inhibitory role of guanosine 3', 5'-monophosphate in ADP-induced human platelet aggregation in the presence of nitric oxide and related vasodilatorsBlood, 1981
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980